Please Wait a Moment
X

Articles

28Jan

CTS to Implement Licensed Babesia testing

28 Jan, 2020 | Return|

In response to the FDA guidance document for Babesia, CTS will implement the licensed Grifols  Babesia test for samples received on April 20, 2020 at the Charlotte, Dallas, Phoenix, St. Louis and Tampa laboratories. Be watching for details on an upcoming webinar that will provide you with an overview of implementing this testing.

Check out the Communication page for the complete details by clicking the link: Communications

Related

Happy New Year!

We are very excited to launch our new website! Please take a few moments to click around and explore...

Read More >

Reminder-Revised Client Forms

 Just a reminder that the revised client forms implement today! Don't forget to toss your o...

Read More >

2020 Annual CTS Survey

The CTS 2020 Annual Laboratory Survey is on its way to your email box. We would appreciate you takin...

Read More >

Reminder- CTS Form Revisions Implement on September 2, 2019

Reminder - Five CTS Forms will be updated on Monday September 2, 2019. Some of the forms are posted ...

Read More >

FDA Releases Zika Virus (ZIKV) Guidance and Grifols ZIKV Assay Licensed

On July 6, 2018 the FDA released an industry guidance document for transitioning from individual to ...

Read More >

COVID-19 Antibody Testing Frequently Asked Questions

The recent communication regarding the recent Anti-SARS-CoV-2 Total assay in Tampa has brought about...

Read More >